SONELOKIMAB
UNII LEN0OCZ4SH

Substance Identification & Data

This profile provides standardized clinical and technical data for Sonelokimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) LEN0OCZ4SH.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1414386-05-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

LEN0OCZ4SH

CAS Registry Number

1414386-05-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SONELOKIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C171838

National Cancer Institute reference terminology for clinical and research data.

INN ID

11137

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

NO-199

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sonelokimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SONELOKIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G, ANTI-(HUMAN INTERLEUKIN 17F) (HUMAN-LAMA GLAMA NANOBODY CLONE IL17MS3063 .GAMMA.-CHAIN V-D-J REGION FRAGMENT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 9-AMINO ACID LINKER) FUSION PROTEIN WITH IMMUNOGLOBULIN G, ANTI-(HUMAN SERUM ALBUMIN) (HUMAN-LAMA GLAMA NANOBODY CLONE ALB-11 .GAMMA.-CHAIN V-D-J REGION FRAGMENT) FUSION PROTEIN WITH PEPTIDE (SYNTHETIC 9-AMINO ACID LINKER) FUSION PROTEIN WITH IMMUNOGLOBULIN G, ANTI-(HUMAN INTERLEUKIN 17A) (HUMAN-LAMA GLAMA NANOBODY CLONE IL17MS3069 .GAMMA.-CHAIN V-D-J REGION FRAGMENT)

M-1095 (ANTI-INTERLEUKIN (IL)-17A/F SINGLE-DOMAIN ANTIBODY)

SONELOKIMAB [INN]

SONELOKIMAB [USAN]

SONELOKIMAB [WHO-DD]